FUJIFILM Holdings Corp

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

FUJIFILM Holdings, Inc. engages in the development, production, sales and service of imaging, information, and document solutions. It operates through the following segments: Healthcare, Materials Solutions, Business Innovation and Imaging Solutions. The Healthcare segment provides medical system equipment, contract manufacturing and development of bio pharmaceuticals and drug discovery support materials. The Materials Solutions segment offers electronic materials, display materials, industrial equipment, fine chemicals, recording media, graphic communication system equipment and inkjet equipment. The Business Innovation segment offers digital multi function devices, solutions and services. The Imaging Solutions segment handles color films, digital cameras, optical devices, color paper, services and equipment for photofinishing, and instant photo systems. The company was founded on January 20, 1934 and is headquartered in Tokyo, Japan.

We have assessed FUJIFILM's transition to date as a healthcare business. The conclusion is that they have made material progress, and the outlook is positive. The secular decline in office equipment business needs to be managed, but healthcare should continue to scale via M&A and capex to generate growth overall.

FUJIFILM Holdings: Beginning To Deliver On Healthcare Diversification

LEXINGTON, Mass., Feb. 24, 2021 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic and enterprise imaging and integration, announced that its Fujifilm Systems Integration business launched an American Institute of Architects (AIA) accredited continuing...

Fujifilm Systems Integration Leads American Institute of Architects Accredited Course on Technological & Design Considerations for Operating Room Integration

LEXINGTON, Mass., Feb. 10, 2021 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, and part of the greater Fujifilm Healthcare portfolio, is proud to introduce its first complete VXR Veterinary X-Ray Room. The...

Fujifilm Launches VXR Veterinary X-Ray Room, a Digital Radiography System Dedicated to Veterinary Imaging

BOTHELL, Wash., Feb. 8, 2021 /PRNewswire/ -- FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound (POCUS) solutions, and the CHEST Foundation, the charitable foundation of the American College of Chest Physicians, announced two recipients of the CHEST Foundation's...

FUJIFILM Sonosite And The Chest Foundation Celebrate Grant Winners Of Ultrasonography And COVID-19 Research Program

LEXINGTON, Mass., Feb. 2, 2021 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc., a leading provider of enterprise imaging and informatics solutions, has ranked #1 in KLAS Research's 2021 'Best in KLAS' report for the company's Synapse® Vendor Neutral Archive (VNA) for the second year...

Fujifilm's Synapse Vendor Neutral Archive Ranks #1 in 2021 'Best in KLAS' Report for Second Consecutive Year

NEW YORK, Jan. 27, 2021 /PRNewswire/ -- B&H is excited to announce three new products for the FUJIFILM X-Series—the X-E4 mirrorless camera, the XF 70-300mm f/4-5.6 R LM OIS WR telephoto zoom, and a redesigned XF 27mm f/2.8 R WR compact prime lens. FUJIFILM introduced the X-E4...

FUJIFILM Launches the X-E4 Mirrorless Camera, XF 70-300mm f/4-5.6 Lens, and Redesigned XF 27mm Lens; More Info at B&H

NEW YORK--(BUSINESS WIRE)--FUJIFILM GFX 100S this camera is poised to shake up the medium format market by packing an ultra-high-resolution sensor into a notably compact body.

FUJIFILM Releases GFX 100S Mirrorless Medium Format Camera and GF 80mm f/1.7; More Info at B&H

Fujifilm Holdings Corp said on Wednesday it will invest $2 billion to establish new large-scale cell culture production site in the United States.

Fujifilm says will invest $2 billion in new large-scale cell culture production site in U.S

TOKYO, Jan. 6, 2021 /PRNewswire/ -- FUJIFILM Corporation (President: Kenji Sukeno) is making an investment of more than 200 Billion yen (2 Billion USD) to establish a new large-scale cell culture production site in the United States to accelerate the growth of its biopharmaceutical...

Fujifilm to Invest Over 200 Billion yen (2 Billion USD) to Establish New Large-Scale Cell Culture Manufacturing Site for Biopharmaceuticals in the U.S.A.

Axon Enterprise

Kratos Defense & Security Solutions

Lemonade

Ocean Power Technologies

PayPal

The markets are a tricky place to navigate in this second wave of the pandemic, so your best hope could be in game-changing stocks. The post 8 Game-Changing Stocks to Buy for Upside and Innovation appeared first on InvestorPlace.

8 Game-Changing Stocks to Buy for Upside and Innovation

LEXINGTON, Mass., Nov. 19, 2020 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, will demonstrate the FDR D-EVO III, an industry-first, glass-free digital radiography (DR) detector with Irradiated Side...

Fujifilm Presents Enhanced Digital Radiography (DR) Solutions with the Availability of the world's first glass-free DR detector with ISS technology in the U.S. and the Expansion of New Digital X-ray Suites

LEXINGTON, Mass. and BOTHELL, Wash., Nov. 19, 2020 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc. and FUJIFILM Sonosite, Inc. announced today the companies will virtually exhibit their portfolios of medical and enterprise imaging solutions at the 2020 Radiological Society of North...

Fujifilm Showcases Comprehensive Portfolio of Medical and Enterprise Imaging Solutions at the Digital RSNA 2020 Conference

Preliminary data is encouraging, but the influenza and COVID-19 treatment's success might not be able to make investors rich.

Is Fujifilm's Avigan a Game-Changing Coronavirus Drug?

Fujifilm Holdings Corp said on Thursday that it had signed a manufacturing contract agreement with U.S.-based firm VLP Therapeutics for a COVID-19 vaccine formulation.

Fujifilm signs manufacturing contract with U.S. firm VLP for COVID-19 vaccine

Fujifilm Instax Square SQ1 simplifies selfies for instant film fans

COLLEGE STATION, Texas, Aug. 19, 2020 /PRNewswire/ -- FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, held a virtual ground-breaking ceremony on August 19, 2020 to signal the.

FUJIFILM Diosynth Biotechnologies Breaks Ground For Advanced Therapies Innovation Center In Texas

FUJIFILM's (FUJIY) fiscal first-quarter results reflect coronavirus impact on the top line and operating income.

FUJIFILM (FUJIY) Q1 Earnings Top Estimates, Revenues Drop Y/Y

Fujifilm Holdings Corp. 4901, +3.09% said Monday it will receive federal funding to help manufacture COVID-19 vaccines.

Fujifilm subsidiary to receive federal funding to manufacture COVID-19 vaccine

Fujifilm Holdings Corporation (OTC: FUJIF) has been awarded a $265 million federal contract to support the manufacturing of novel coronavirus (COVID-19) vaccine candidate, the United States Department of Health and Human Services announced Monday.

Fujifilm Gets $265M Federal Contract To Support Coronavirus Vaccine Manufacturing

COLLEGE STATION, Texas, July 27, 2020 /PRNewswire/ -- FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, announced today that its College Station, Texas, site will support COVID-19.

FUJIFILM Diosynth Biotechnologies Texas Facility to Support COVID-19 Vaccine Candidate Manufacturing

President Trump announced on Monday that the U.S. government has awarded Fujifilm a $265 million contract to expand the country’s coronavirus vaccine manufacturing capacity.

President Trump announces $265 million award to Fujifilm for coronavirus vaccine manufacturing

Fujifilm Holdings Corp  will spend $928 million to double capacity at a drug manufacturing facility in Denmark, which it has pledged to use in producing COVID-19 treatments, as the Japanese company steps up its pivot towards healthcare.

Japan's Fujifilm to spend $928 million to double capacity of Danish drug facility

Shares of Fujifilm 4901, -2.56% fell 2.7% in Tokyo on Wednesday amid doubts over a treatment for coronavirus infections.

Fujifilm shares fall amid doubts about Covid-19 treatment Avigan

Shares of Fujifilm Holdings Corp  tumbled more than 4% in early trade on Wednesday after a report its anti-flu drug Avigan was not showing apparent efficacy in coronavirus treatment in clinical trials so far.

Fujifilm shares tumble after report Avigan not showing apparent efficacy in coronavirus treatment

FUJIFILM (FUJIY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season

News for FUJIFILM Holdings Corp Stock (FUJIY)